Safety, immunogenicity, and lot consistency of a 13-valent pneumococcal conjugate vaccine in Chinese children aged 2-5 years: A phase III study. Shi L, Chen J, Li H, Yan X, et al. Vaccine 2026;75:128244.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shi L, Chen J, Li H, Yan X, et al. Safety, immunogenicity, and lot consistency of a 13-valent pneumococcal conjugate vaccine in Chinese children aged 2-5 years: A phase III study. Vaccine 2026;75:128244.
PMID: 41554243